DIC India Fair Value
DIC India (DICIND) average fair value is ₹939.26 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹507.8 (+84.97%), fair value range ₹423.78–₹2852.64. Also explore DICIND share price data to track price trends across different timeframes.
Fair Value Analysis Export
DICIND Fair Value vs Current Price — Valuation Summary
DICIND average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit DIC India share price chart.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
DICIND Fair Value Analysis — Data Sources & Coverage
DIC India financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. See DICIND book value to compare market price against book value per share.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
DICIND vs Chemicals Sector Peers — P/E, P/B & Market Cap
DIC India P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Polychem | POLYCHEM | 2.51 | 1.71 | ₹82 |
| HP Adhesives | HPAL | 48.29 | 1.8 | ₹338 |
| Blue Pearl Agriventures | BPAGRI | 2450.0 | 24.2 | ₹1,476 |
| PB Global | PBGLOBAL | -0.06 | 0.01 | ₹0 |
| Omkar Pharmachem | OMKARPH | 337.5 | 2.86 | ₹27 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.